PHD Chamber of Commerce and Industry organized conference on the classification of health products “Health Horizons: Defining the Future of Health Products” at PHD House, New Delhi. The event brought together key industry leaders and policymakers to discuss the future of health products in India. Dr.
Genes2Me Pvt. Ltd, one of the leading diagnostic laboratories in India, has announced the launch of its Rapi-Q- Point of Care RTPCR solution for 1-8 samples, which is easy to use and gives faster results in less than 45 minutes. Backed by powerful software analysis
Genes2Me announced today the launch of its wide range of Next-generation sequencing (NGS)-based panels for Oncology, Personalized Medicine and Hereditary Diseases. By selectively targeting the clinically significant genes, the NGS panels from Genes2Me enable comprehensive analysis with the most effective sequencing throughput. These panels have
Genes2Me, India's leading manufacturer of IVD kits and Point of care solutions, has recently launched COVFlu Real-Time PCR kit, which accurately detects Influenza A/B, RSV and SARS-CoV-2. With this kit, Influenza A/B, RSV, RNaseP, and COVID-19 can be accurately detected simultaneously with just one single
